Loading...
Loading...
CME Group Inc.
CME reports Q4 EPS of $0.63 versus the estimated $0.64, missing by $0.01. EPS were Down 11% from the same quarter last year. Revenue came in at $660.90M versus the estimated $664.16M. Sales were Down 11% year over year.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in